Delivery Order SPE2DR25D6028-SPE2DR26FASMR
- Not listed
- The Defense Logistics Agency awarded a $3,318.84 delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Junel FE 1mg-20 168s pharmaceutical product, with completion scheduled for December 5, 2025. This competitively awarded, firm fixed-price delivery order is being performed in Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. The award carries no set-aside designation and is classified as a child contract under a larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,076.91 to AmerisourceBergen Drug Corp for Junel FE 1 mg-20 mcg tablets (28-count packaging) on November 20, 2025, with completion targeted for November 21, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single pharmaceutical delivery under the Defense Logistics Agency's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $3,427.92 to AmerisourceBergen Drug Corp for Junel FE 1MG-20 168S pharmaceutical product. This firm fixed price, non-competitive delivery order was issued on September 24, 2025, with an ultimate completion date of September 25, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child order under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Junel Fe 1 mg-20 mcg tablets (28-count) with a ceiling value of $1,921.22. This firm fixed-price, competitively awarded delivery order is scheduled for completion by December 2, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $2,046.60 delivery order to AmerisourceBergen Drug Corp for Junel FE 1 mg-20 mcg tablets (28-count packaging) on July 22, 2025, with completion scheduled for July 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the...
- The Defense Logistics Agency awarded a delivery order valued at $1,904.40 to AmerisourceBergen Drug Corp for Junel FE 1 mg–20 mcg tablets (28-count packages) on August 21, 2025, with an ultimate completion date of August 22, 2025. This firm fixed-price, competitively awarded delivery order represents a non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a $1,678.88 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Junel FE 1.5 mg-30 mcg tablets in quantities of 28 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of September 10, 2025. This delivery order is a child contract...
- The Defense Logistics Agency awarded a $3,637.67 delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Junel FE 1 mg-20 mcg tablets (28-count packaging). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 18, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a small-value pharmaceutical procurement falling under the company's larger federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,365.51 to AmerisourceBergen Drug Corp for the supply of Junel FE 1.5 mg-30 mcg tablets (28-count packages) under a firm fixed price contract. The award, issued on November 26, 2025, with an ultimate completion date of November 28, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,697.57 to AmerisourceBergen Drug Corp for JUNEL FE 1MG-20 168S, a hormonal contraceptive medication. This non-set-aside, firm fixed price delivery order was awarded on November 25, 2025, with an ultimate completion date of November 26, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order represents...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FASMRDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,061.45 to AmerisourceBergen Drug Corp for JUNEL FE 1MG-20 168S, a pharmaceutical product, with a completion date of December 9, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The place of performance is located at the contractor's corporate office in Conshohocken, PA. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. The company has demonstrated its capability to fulfill federal medical procurement requirements through open competition across multiple therapeutic domains, positioning it as a critical vendor within the DLA's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 12/7/25 |